| Type of Product |
Medicine |
| TGA Recall Reference |
RC-2015-RN-00175-1 |
| Product Name/Description |
HALCION (triazolam) & PONSTAN (mefenamic acid) & XANAX (alprazolam) - All Batches
HALCION (triazolam) 0.125 mg tablets, Bottles of 50
AUST R number: 12304
PONSTAN (mefenamic acid) 250 mg capsules, Bottles of 50
AUST R number: 14387
XANAX (alprazolam) 2mg Tablets, Bottles of 50
AUST R number: 53931 |
| Recall Action Level |
Consumer |
| Recall Action Classification |
Class II |
| Recall Action Commencement Date |
5/03/2015 |
| Responsible Entity |
|
| Reason/Issue |
It has come to the attention of Pfizer Australia that Halcion 0.125 mg tablets, Ponstan 250 mg capsules and Xanax 2 mg tablets have been supplied to the market in containers without child-resistant closures.
This gives rise to a potential for inadvertent poisoning, particularly where affected product is not stored out of the reach of children as required with all medicines.
All of these products are Prescription only.
Xanax was discontinued in December 2013, however all batches are still subject to this Recall Action.
Consumers are asked to return affected product to their pharmacy for a refund. |
| Recall Action |
Recall |
| Recall Action Instructions |
All batches are being Recalled from the Market This action has been closed-out on 9/08/2016. |
| Contact Information |
1800 999 543 -for Pharmacists;
1800 675 229 – for Patients |